TOCILIZUMAB, FLUDARABINE PHOSPHATE, YTB323, CYCLOPHOSPHAMIDE
CYTB323N12101
Phase 2 small_molecule active
Quick answer
TOCILIZUMAB, FLUDARABINE PHOSPHATE, YTB323, CYCLOPHOSPHAMIDE for Relapsing Multiple Sclerosis is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Relapsing Multiple Sclerosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active